Xiamen AmonMed Biotechnology Co., Ltd., founded in 2014, is a national high-tech enterprise engaged in rare earth biomedical transformation technology. It is incubated by the Chinese Academy of Sciences and jointly invested and established by leizhi group (A-share listed company, stock code: 002398), well-known medical investment fund Zhejiang saibole fund, Shanghai Taoyuan science and technology center, etc R & D, production and sales of external diagnostic products.

As a rare earth biomedical enterprise incubated by the Haixi Innovation Research Institute of the Chinese Academy of Sciences, aode biology has a technical team led by academician Hong Maochun, relying on the scientific research platform of the Chinese Academy of Sciences, with strong R & D strength and technological strength. Has undertaken the completion of a number of national, Chinese Academy of Sciences Projects. At present, we have many patents, and have successfully developed a series of in vitro rare earth nano-fluorescent immunodiagnostic products with independent intellectual property rights. Among them, 27 products have passed the EU CE certification, 32 rare earth diagnostic kits and 2 rare earth nano-fluorescence immunoassay instruments have obtained the national medical device registration certificate.Xiamen AmonMed Biotechnology Co., Ltd., founded in 2014, is a national high-tech enterprise engaged in rare earth biomedical transformation technology. It is incubated by the Chinese Academy of Sciences and jointly invested and established by leizhi group (A-share listed company, stock code: 002398), well-known medical investment fund Zhejiang saibole fund, Shanghai Taoyuan science and technology center, etc R & D, production and sales of external diagnostic products.

As a rare earth biomedical enterprise incubated by the Haixi Innovation Research Institute of the Chinese Academy of Sciences, aode biology has a technical team led by academician Hong Maochun, relying on the scientific research platform of the Chinese Academy of Sciences, with strong R & D strength and technological strength. Has undertaken the completion of a number of national, Chinese Academy of Sciences Projects. At present, we have many patents, and have successfully developed a series of in vitro rare earth nano-fluorescent immunodiagnostic products with independent intellectual property rights. Among them, 27 products have passed the EU CE certification, 32 rare earth diagnostic kits and 2 rare earth nano-fluorescence immunoassay instruments have obtained the national medical device registration certificate.